IBOK
ALXN

Independence Bank of Kentucky’s Alexion Pharmaceuticals ALXN Stock Holding History

Independence Bank of Kentucky’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33
Closed -$4K – 395
2018
Q1 		$4K Buy
+33
New +$3.94K ﹤0.01% 339

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Independence Bank of Kentucky's ALXN Position: Q2 2018 in Review

Independence Bank of Kentucky sold out of Alexion Pharmaceuticals (ALXN) in Q2 2018, closing a stake of 33 shares — an estimated $4K sold.

Independence Bank of Kentucky first reported a position in ALXN in Q1 2018 and held it in 1 quarter. The position peaked at $4K in Q1 2018. 601 funds tracked by Wall St. Rank hold ALXN as of Q2 2018.

  • Independence Bank of Kentucky reported no remaining Alexion Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Independence Bank of Kentucky sold 33 Alexion Pharmaceuticals shares in Q2 2018, an estimated $4K.
  • Independence Bank of Kentucky first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Independence Bank of Kentucky's Alexion Pharmaceuticals position peaked at $4K in Q1 2018.
  • 601 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2018.

Based on Independence Bank of Kentucky's 13F filing for Q2 2018, filed 7 Aug 2018.